Hoang, Tung http://orcid.org/0000-0001-6653-3406
Cho, Sooyoung http://orcid.org/0000-0002-9605-9685
Choi, Ji-Yeob http://orcid.org/0000-0001-5365-8189
Kang, Daehee http://orcid.org/0000-0003-4031-5878
Shin, Aesun http://orcid.org/0000-0002-6426-1969
Funding for this research was provided by:
National Research Foundation of Korea (2022R1A2C1004608, 2022R1A2C1004608, 2022R1A2C1004608)
Article History
Received: 3 August 2023
Accepted: 5 October 2023
First Online: 18 October 2023
Declarations
:
: UK Biobank received ethical approval from the NHS National Research Ethics Service North West (16/NW/0274) and was performed in line with the principles of the Declaration of Helsinki. Approval of the current study was granted by the Institutional Review Board of Seoul National University (No. 2209–046-1357). Informed consent was obtained for all UK Biobank participants. This research was conducted under UK Biobank application number 94695.
: Not applicable.
: The corresponding author, Aesun Shin, is an Editorial Board Member (Associate Editor) of BMC Cancer. The other authors declare that they have no competing interests.